Oxy 50mg 50 Tablets Nakon Medical USA
$85.00
Product Short Description
Oxy 50mg 50 Tablets Nakon Medical USA delivers oxymetholone (C21H32O3), the 2-hydroxymethylene-17α-methyl-dihydrotestosterone derivative exhibiting extreme anabolic potency (~320:45 ratio) with rapid mass response, at exact 50 mg strength replicating historical Anadrol-50 formulation. Domestic U.S. production eliminates customs exposure serving DEA Schedule III compliant institutional channels exclusively through verified performance networks.
Product Overview
Nakon Medical USA’s Oxy 50 mg presents oxymetholone, featuring unique 2α-hydroxymethylene substitution conferring unparalleled oral bioavailability (~8-9 hour half-life) and erythropoietic stimulation alongside profound protein synthesis, in white round scored tablets precisely matching Anadrol-50 (Unimed) morphology for seamless institutional catalog integration across DEA-registered platforms. The 50-tablet HDPE bottle configuration supports CIII-compliant inventory reconciliation under 21 CFR 1304.22 requiring detailed Schedule III tracking for institutional handlers maintaining federal compliance.
U.S.-domiciled GMP manufacturing maintains molecular specifications (MW 332.48) matching FDA reference standards while distinguishing legitimate Schedule III pedigree from underground powder conversions exhibiting characteristic 60-80% under-dosing documented across independent analytics. This authentic prescription-equivalent presentation serves advanced institutional buyers requiring verified batch traceability through serialized lot numbering essential for Form 222 triplicate documentation and controlled substance accountability, eliminating international sourcing risks inherent to grey-market alternatives.
Nakon Oxy positions exclusively within verified DEA Schedule III ecosystems targeting licensed institutional clientele demonstrating high-potency anabolic handling protocols under 21 CFR 1301.13 registrant requirements, maintaining strict commercial positioning devoid of therapeutic claims or performance guidance.
Brand & Manufacturer Information
Nakon Medical USA manufactures DEA Schedule III controlled substances through domestic GMP facilities serving institutional performance networks requiring rigorous DEA registrant verification prior to encrypted fulfillment. Oxy 50 mg anchors Nakon’s extreme oral anabolic catalog alongside Dbol/Tbol maintaining historical 50 mg standardization while authenticating supply chain legitimacy versus powder-pressed underground alternatives rejected universally by institutional handlers.
Domestic climate-controlled warehousing supports Form 222 platforms eliminating customs seizure risk while serialized batch documentation verifies 50 mg potency through independent HPLC assay distinguishing Nakon from non-pharmaceutical origins lacking controlled substance pedigree essential for institutional procurement.
Active Compound Information
Contains oxymetholone (17α-methyl-2-hydroxymethylene-5α-androstan-3-one), exhibiting 2α-hydroxymethylene modification conferring unprecedented anabolic:androgenic activity characteristic of 17α-alkylated DHT derivatives with exceptional oral absorption preventing first-pass inactivation. DEA Schedule III classification under Anabolic Steroid Control Act reflects profound hepatotoxicity, water retention, erythropoiesis stimulation, and cardiovascular risk profile necessitating short-duration administration.
50 mg strength precisely matches historical Anadrol-50 (NDC 0051-8633-33) reference while 50-tablet count supports institutional packaging exceeding standard 100-count pharmacy bottles. Molecular formula C21H32O3; WADA S1.1a prohibited globally.
Product Specifications
| Specification | Details |
|---|---|
| Product Name | Oxy 50mg 50 Tablets Nakon Medical USA |
| Active Compound | Oxymetholone (C21H32O3) |
| Strength | 50 mg per white round scored tablet |
| Quantity | 50 tablets per HDPE bottle |
| Form | Oral scored tablets (Anadrol equivalent) |
| Category | DEA Schedule III controlled substance |
| Appearance | White, round, single-scored |
| Molecular Weight | 332.48 g/mol |
| Half-Life | ~8-9 hours |
| Label Elements | “50 mg”, CIII warnings, serialized lot |
Quality Control & Testing Standards
50 mg oxymetholone mandates USP <621> potency assay (HPLC 95-105% label claim), USP <711> dissolution (Q=85% 30 minutes), USP <905> uniformity, and hydroxymethylene verification confirming pharmaceutical-grade specifications matching historical Anadrol monographs. Nakon batch records document C21H32O3 identity distinguishing legitimate GMP production from underground conversions.
50-tablet CIII configuration incorporates USP <671> HDPE barriers preventing oxidative degradation while child-resistant closure satisfies 21 CFR 310.310(a) Schedule III requirements. Domestic stability maintains ICH Q1A(R2) 40°C/75%RH confirming 24-month shelf-life.
Intended Use & Market Positioning
Oxy 50 mg serves DEA-registered CIII institutional researchers managing extreme Schedule III anabolic inventories exclusively through encrypted fulfillment requiring Form 222 accountability. Prescription-equivalent positioning serves verified institutional clientele.
Zero protocols, cycles, stacking, PCT, or outcomes represented maintaining commercial CIII positioning.
Legal & Regulatory Disclaimer
Oxymetholone constitutes DEA Schedule III under 21 USC §812; non-medical handling violates Controlled Substances Act (5 years/$250,000 penalties). Institutional buyers assume Form 222/DEA licensing liability; no medical claims provided.
MAECENAS IACULIS
Vestibulum curae torquent diam diam commodo parturient penatibus nunc dui adipiscing convallis bulum parturient suspendisse parturient a.Parturient in parturient scelerisque nibh lectus quam a natoque adipiscing a vestibulum hendrerit et pharetra fames nunc natoque dui.
ADIPISCING CONVALLIS BULUM
- Vestibulum penatibus nunc dui adipiscing convallis bulum parturient suspendisse.
- Abitur parturient praesent lectus quam a natoque adipiscing a vestibulum hendre.
- Diam parturient dictumst parturient scelerisque nibh lectus.
Scelerisque adipiscing bibendum sem vestibulum et in a a a purus lectus faucibus lobortis tincidunt purus lectus nisl class eros.Condimentum a et ullamcorper dictumst mus et tristique elementum nam inceptos hac parturient scelerisque vestibulum amet elit ut volutpat.
Reviews
There are no reviews yet.